HeartSciences Reports First Quarter Fiscal 2024 Financial Results
14 sept. 2023 16h15 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase
12 sept. 2023 16h15 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards
11 sept. 2023 16h15 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India
07 sept. 2023 09h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences Signs Distribution Agreement with FJ Medical, Denmark
31 août 2023 09h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based...
HeartSciences’ MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation
24 août 2023 09h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio
17 août 2023 09h00 HE
|
Heart Test Laboratories, Inc.
Southlake, TX, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark
27 juil. 2023 09h00 HE
|
Heart Test Laboratories, Inc.
Southlake, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results
19 juil. 2023 09h00 HE
|
Heart Test Laboratories, Inc.
Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...
HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine
17 mai 2023 08h00 HE
|
Heart Test Laboratories, Inc.
Southlake, Texas, May 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...